1. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998; 17: 291-6.
2.
Basra MKA, Finlay AY. The family impact of skin diseases: the greater patient concept. Br J Dermatol 2007; 156: 929-37.
3.
Golics CJ, Basra MKA, Salek MS, Finlay AY. The impact of disease on family members: a critical aspect of medical care.
4.
J R Soc Med 2013; 106: 399-407.
5.
Golics CJ, Basra MKA, Salek MS, Finlay AY. The impact of patients’ chronic disease on family quality of life: an experience from 26 specialties. Int J Gen Med 2013; 6: 787-98.
6.
Salek S, Finlay AY, Basra MKA, Golics CJ. The development and validation of the Family Reported Outcome Measure (FROM-16)© to assess the impact of disease on the partner or family member. Quality Life Res 2014; 23: 317-26.
7.
Shah R, Finlay AY, Salek SM, et al. Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK BMJ Open 2023; 13: e066168.
8.
Wójcik E, Reszke R, Otlewska A, et al. Family Reported Outcome Measure-16 (FROM-16): creation, reliability and reproducibility of the Polish language version. Acta Derm Venereol 2020; 100: adv00219.
9.
Isaacs BJ, Brown I, Brown RI, et al. The International Family Quality of Life Project: Goals and Description of a Survey Tool. J Policy Pract Intell Disab 2007; 4: 177-85.
10.
Brown I, Brown RI, Baum NT, et al. Family Quality of Life Survey: General Version. Toronto, ON, Canada: Surrey Place Centre 2006.
11.
Rossi Ferrario S, Baiardi P, Zotti AM. Update on the Family Strain Questionnaire: a tool for the general screening of caregiving-related problems. Qual Life Res 2004; 13: 1425-34.
12.
Vidotto G, Ferrario SR, Bond TG, Zotti AM. Family Strain Questionnaire – Short Form for nurses and general practitioners. J Clin Nurs 2010; 19: 275-83.
13.
Stein REK, Riessman CK. The development of an Impact-on-Family Scale: preliminary findings. Med Care 1980; 18: 465-72.
14.
Stein REK, Jessop DJ. The Impact on Family Scale revisited: further psychometric data. J Dev Behav Pediatr 2003; 24: 9-16.
15.
Williams AR, Piamjariyakul U, Williams PD, et al. Validity of the revised Impact on Family (IOF) scale. J Pediatr 2006; 149: 257-61.
16.
Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37: 126-39.
17.
Varni JW, Sherman SA, Burwinkle TM, et al. The PedsQL Family Impact Module: preliminary reliability and validity. Health Qual Life Outcomes 2004; 2: 55.
18.
Hoffman L, Marquis J, Poston D, et al. Assessing family outcomes: psychometric evaluation of the Beach Center Family Quality of Life Scale. J Marriage Fam 2006; 68: 1069-83.
19.
Park J, Hoffman L, Marquis J, et al. Toward assessing family outcomes of service delivery: validation of a family quality of life survey. J Intellect Disabil Res 2003; 47: 367-84.
20.
Poston D, Turnbull A, Park J, et al. Family quality of life: a qualitative inquiry. Mental Retardation 2003; 41: 313-28.
21.
Wang M, Turnbull AP, Summers JA, et al. Severity of disability and income as predictors of parents’ satisfaction with their family quality of life during early childhood years. Res Pract Persons Sev Disabil 2004; 29: 82-94.
22.
Summers JA, Poston DJ, Turnbull AP, et al. Conceptualizing and measuring family quality of life. J Intellect Disabil Res 2005; 49: 777-83.
23.
Brouwer WB, van Exel NJ, van Gorp B, Redekop WK. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res 2006; 15: 1005-21.
24.
Basra MK, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-38.
25.
Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138:
26.
107-13.
27.
Basra MKA, Edmunds O, Salek MS, Finlay AY. Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). J Eur Acad Dermatol Venereol 2008; 22: 813-21.
28.
Marciniak J, Reich A, Szepietowski J. The Family Dermatology Life Quality Index – formulation and validation of the Polish version. Forum Dermatologicum 2016; 2: 24-8.
29.
Dodington SR, Basra MK, Finlay AY, Salek MS. The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. Br J Dermatol 2013; 169: 31-46.
30.
McKenna SP, Whalley D, Dewar AL, et al. International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res 2005; 14: 231-41.
31.
Meads DM, McKenna SP, Kahler K. The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores. Qual Life Res 2005; 14: 2235-45.
32.
Whalley D, Huels J, McKenna SP, van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parent’s quality of life in the treatment of paediatric atopic dermatitis. Pediatrics 2002; 110: 1133-6.
33.
Kondo-Endo K, Ohashi Y, Nakagawa H, et al. Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD). Br J Dermatol 2009; 161: 617-25.
34.
Katsunuma T, Tan A, Ohya Y. [Short version of a quality-of-life questionnaire in primary caregivers of children with atopic dermatitis (QPCAD): development and validation of QP9]. Arerugi 2013; 62: 33-46.
35.
Chamlin SL, Frieden IJ, Williams ML, Chren MM. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004; 114: 607-11.
36.
Chamlin SL, Cella D, Frieden IJ, et al. Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005; 125: 1106-11.
37.
Chamlin SL, Lai JS, Cella D, et al. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol 2007; 143: 768-72.
38.
Méni C, Bodemer C, Toulon A, et al. Atopic dermatitis burden scale: creation of a specific burden questionnaire for families. J Eur Acad Dermatol Venereol 2013; 27: 1426-32.
39.
Eghlileb AM, Basra MK, Finlay AY. The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis. Dermatology 2009; 219: 63-70.
40.
Basra MK, Zammit AM, Kamudoni P, et al. PFI-14©: a rasch analysis refinement of the Psoriasis Family Index. Dermatology 2015; 231: 15-23.
41.
Mrowietz U, Hartmann A, Weißmann W, Zschocke I. FamilyPso – a new questionnaire to assess the impact of psoriasis on partners and family of patients. J Eur Acad Dermatol Venereol 2017; 31: 127-34.
42.
Dufresne H, Hadj-Rabia S, Taieb C, Bodemer C. Development and validation of an epidermolysis bullosa family/parental burden score. Br J Dermatol 2015; 173: 1405-10.
43.
Dufresne H, Hadj-Rabia S, Méni C, et al. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis 2013; 8: 28.
44.
Boccara O, Méni C, Léauté-Labreze C, et al. Haemangioma family burden: creation of a specific questionnaire. Acta Derm Venereol 2015; 95: 78-82.
45.
Agrawal S, Satapathy S, Gupta V, et al. Family vitiligo impact scale: a scale to measure the quality-of-life of family members of patients with vitiligo. Indian J Dermatol Venereol Leprol 2021; 88: 32-9.
46.
Erfurt-Berge C, Ronicke M, Richter-Schmidinger T, et al. Quality of life assessment in family members of patients with chronic wounds. Eur J Dermatol 2019; 29: 484-9.
47.
World Health Organization. WHO Constitution. Geneva WHO 1948.
48.
Elkington JR. Medicine and the quality of life. Ann Intern Med 1966; 64: 711-4.
49.
Albrecht GL. Subjective health assessment. In: Measuring Health and Medical Outcomes. Jenkinson C ed. UCL London 1994; 7–26.
50.
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9.
51.
Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980; 20: 649-55.
52.
Sampogna F, Finlay AY, Salek SS, et al.; European Academy of Dermatology and Venereology TaskForce on Quality of Life. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol 2017; 31: 1429-39.
53.
Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118: 622-9.
54.
Lohr KN. Assessing health status and quality of life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193-205.
55.
Aaronson NK. Quantitative issues in health-related quality of life assessment. Health Policy 1988; 10: 217-30.
56.
Wood-Dauphinee S. Assessing quality of life in clinical research. J Clin Epidemiol 1999; 52: 355-63.
57.
Chernyshov PV, Kaliuzhna LD, Reznikova AA, Basra MK. Comparison of the impairment of family quality of life assessed by disease-specific and dermatology-specific instruments in children with atopic dermatitis. J Eur Acad Dermatol Venereol 2015; 29: 1221-4.
58.
Martínez-García E, Arias-Santiago S, Herrera-Acosta E, et al. Quality of life of cohabitants of people living with acne. Acta Derm Venereol 2020; 100: adv00290.
59.
Bin Saif GA, Al-Balbeesi AO, Binshabaib R, et al. Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia. Am J Clin Dermatol 2013; 14: 489-95.
60.
Kouris A, Christodoulou C, Efstathiou V, et al. Quality of life in Greek family members living with leg ulcer patients. Wound Repair Regen 2015; 23: 778-80.
61.
Jones DA, Peters TJ. Caring for elderly dependants: effects on the carer’s quality of life. Age Ageing 1992; 21: 421-8.
62.
Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007; 156: 1245-50.
63.
Kornblith AB, Herr HW, Ofman US, et al. Quality of life of patients with prostate cancer and their spouses. Cancer 1994; 73: 2791-802.
64.
Axelsson B, Sjoden P. Quality of life of cancer patients and their spouses in palliative home care. Pall Med 1998; 12: 29-39.
65.
Rees J, O’Boyle C, MacDonagh R. Quality of life: impact of chronic illness on the partner. J R Soc Med 2001; 94: 563-6.
66.
W³odarek K, G³owaczewska A, Matusiak £, Szepietowski JC. Psychosocial burden of hidradenitis suppurativa patients’ partners. J Eur Acad Dermatol Venereol 2020; 34: 1822-7.
67.
Sánchez-Díaz M, Salazar-Nievas MC, Molina-Leyva A, Arias-Santiago S. The burden on cohabitants of patients with chronic spontaneous urticaria: a cross-sectional study.
68.
J Clin Med 2022; 11: 3228.
69.
Sánchez-Díaz M, Díaz-Calvillo P, Ureña-Paniego CA, et al. Quality of life and mood status disturbances in cohabitants of patients with alopecia areata: a cross-sectional study in a Spanish population. Int J Environ Res Public Health 2022; 19: 16323.
70.
Yu DSF, Cheng ST, Wang J. Unravelling positive aspects of caregiving in dementia: an integrative review of research literature. Int J Nurs Stud 2018; 79: 1-26.
71.
Rapp SR, Chao D. Appraisals of strain and of gain: effects on psychological wellbeing of caregivers of dementia patients. Aging Ment Health 2000; 4: 142-7.
72.
Quinn C, Toms G. Influence of positive aspects of dementia caregiving on caregivers’ well-being: a systematic review. Gerontologist 2019; 59: e584-96.
73.
Vermaes IP, van Susante AM, van Bakel HJ. Psychological functioning of siblings in families of children with chronic health conditions: a meta-analysis. J Pediatr Psychol 2012; 37: 166-84.
74.
Gan LL, Lum A, Wakefield CE, et al. School experiences of siblings of children with chronic illness: a systematic literature review. J Pediatr Nurs 2017; 33: 23-32.
75.
Pilowsky T, Yirmiya N, Doppelt O, et al. Social and emotional adjustment of siblings of children with autism. J Child Psychol Psychiatry 2004; 45: 855-65.
76.
Opperman S, Alant E. The coping responses of the adolescent siblings of children with severe disabilities. Disabil Rehabil 2003; 25: 441-54.
77.
Knecht C, Hellmers C, Metzing S. The perspective of siblings of children with chronic illness: a literature review.
78.
J Pediatr Nurs 2015; 30: 102-16.
79.
Lapidus CS, Kerr PE. Social impact of atopic dermatitis. Med Health RI 2001; 84: 294-5.
80.
O’Brien I, Duffy A, Nicholl H. Impact of childhood chronic illnesses on siblings: a literature review. Br J Nurs 2009; 18: 1358-65.
81.
Alderfer MA, Long KA, Lown EA, et al. Psychosocial adjustment of siblings of children with cancer: a systematic review. Psycho-Oncology 2010; 19: 789-805.
82.
Houtzager BA, Grootenhuis MA, Last BF. Supportive groups for siblings of pediatric oncology patients: impact on anxiety. Psycho-Oncology 2001; 10: 315-24.
83.
Havermans T, Croock ID, Vercruysse T, et al. Belgian siblings of children with a chronic illness. J Child Health Care 2013; 19: 154-66.
84.
Yang EJ, Beck KM, Sekhon S, et al. The impact of pediatric atopic dermatitis on families: a review. Pediatr Dermatol 2019; 36: 66-71.
85.
Caicedo C. Families with special needs children. J Am Psych Nurses Assoc 2014; 20: 398-407.
86.
Lin VW. Tough-skinned kids: identifying psychosocial effects of psoriasis and helping pediatric patients and families cope. J Pediatr Nurs 2012; 27: 563-72.
87.
Neri I, Galli E, Baiardini I, et al. Implications of Atopic Dermatitis on the Quality of Life of 6-11 Years Old Children and Caregivers (PEDI-BURDEN). J Asthma Allergy 2023; 16: 383-96.
88.
Pauli-Pott U, Darui A, Beckmann D. Infants with atopic dermatitis: maternal hopelessness, child-rearing attitudes and perceived infant temperament. Psychother Psychosom 1999; 68: 39-45.
89.
Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. J Clin Pract 2006; 60: 984-92.
90.
Kim E, Fischer G. Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice. Austral J Dermatol 2021; 62: 190-4.
91.
Elliott BE, Luker K. The experiences of mothers caring for a child with severe atopic eczema. J Clin Nurs 1997; 6: 241-7.
92.
Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138: 107-13.
93.
Ezzedine K, Shourick J, Merhand S, et al. Impact of atopic dermatitis in adolescents and their parents: a French study. Acta Derm Venereol 2020; 100: adv00294.
94.
Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997; 76: 159-62.
95.
Ju HJ, Seo JM, Kim SH, et al. Quality of life in parents of children and adolescents with vitiligo: a qualitative study. Ann Dermatol 2023; 35: 472-5.
96.
Fine JD, Johnson LB, Weiner M, Suchindran C. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br J Dermatol 2005; 152: 1009-14.
97.
Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin Exp Dermatol 1995; 20: 38-41.
98.
Koblenzer CS, Koblenzer PJ. Chronic intractable atopic eczema. Its occurrence as a physical sign of impaired parent-child relationships and psychologic developmental arrest: improvement through parent insight and education. Arch Dermatol 1988; 124: 1673-7.
99.
McCann D, Bull R, Winzenberg T. Sleep deprivation in parents caring for children with complex needs at home: a mixed methods systematic review. J Fam Nurs 2015; 21: 86-118.
100.
Germo GR, Chang ES, Keller MA, et al. Child sleep arrangements and family life: perspectives from mothers and fathers. Infant Child Dev 2007; 16: 433-56.
101.
Fine JD, Johnson LB, Weiner M, Suchindran C. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br J Dermatol 2005; 152: 1009-14.
102.
Capozza K, Schwartz A, Lang JE, et al. Impact of childhood atopic dermatitis on life decisions for caregivers and families. J Eur Acad Dermatol Venereol 2022; 36: e451-4.
103.
Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69: 670-6.
104.
Chernyshov PV, Ho RC, Monti F, et al. An international multi-center study on self-assessed and family quality of life in children with atopic dermatitis. Acta Dermatovenerol Croat 2015; 23: 247-53.
105.
Jang HJ, Hwang S, Ahn Y, et al. Family quality of life among families of children with atopic dermatitis. Asia Pac Allergy 2016; 6: 213-9.
106.
Marciniak J, Reich A, Szepietowski JC. Quality of life of parents of children with atopic dermatitis. Acta Derm Venereol 2017; 97: 711-4.
107.
Balkrishnan R, Housman TS, Carroll C, et al. Disease severity and associated family impact in childhood atopic dermatitis. Arch Dis Child 2003; 88: 423-7.
108.
Pustisek N, Vurnek Zivkovic M, Situm M. Quality of life in families with children with atopic dermatitis. Pediatr Dermatol 2016; 33: 28-32.
109.
Whalley D, Huels J, McKenna SP, et al. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents’ quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 2002; 110: 1133-6.
110.
Wolf JM, Miller GE, Chen E. Parent psychological states predict changes in inflammatory markers in children with asthma and healthy children. Brain Behav Immun 2008; 22: 433-41.
111.
Buske-Kirschbaum A. Treating the parents to heal the child? Brain Behav Immunity 2008; 22: 431-2.
112.
Adelman RD, Tmanova LL, Delgado D, et al. Caregiver burden. JAMA 2014; 311: 1052.
113.
Marinello E, Linder D, Spoto A, et al. Assessing the Impact of Atopic Dermatitis on the Patients’ Parents with the Visual Instrument “Caregiver-PRISM.” Dermatology 2016; 232: 490-5.
114.
Muzzolon M, Imoto RR, Canato M, et al. Educational intervention and atopic dermatitis: impact on quality of life and treatment. Asia Pac Allergy 2021; 11: e21.
